Biome Australia – Results of Annual General Meeting
Microbiome health company, Biome Australia Limited (ASX:BIO, “Biome” or “the Company”), announces in accordance with Listing Rule 3.13.2 and Section… Read more
Biome Australia – Revenue Update
Revenue Update • Biome surpasses $5m sales revenue for the first five months of the financial year FY24, representing 70%… Read more
Biome Australia Quarterly Activities & Appendix 4C September 2023
● Biome reports record $2.74m sales revenue in Q1 FY24 ● 59% gross margin maintained for Q1 FY24 ● Same-store… Read more
Biome’s first month of positive EBITDA expected in FY24
● Biome expects to achieve positive monthly EBITDA by June 2024 ● Gross margins expected to be maintained above 59%… Read more
Biome Australia’s strong sales drive record quarterly result
● Q1 FY24 Sales reach $2.74m, 74% growth vs the previous corresponding period ● Biome surpasses Q1 FY24 revenue target… Read more
Biome | The Microbiome Health Company
Biome aims to improve the health and quality of life of Australians suffering from some of the most common and… Read more
Biome Australia Change to Date of AGM
Biome Australia Limited (ASX:BIO) (“Company”) advises that, it has changed its date of the Annual General Meeting (AGM) to now… Read more
Biome Australia Limited Appendix 4E Preliminary final report
The Company continued to experience strong sales growth during the year with revenue increasing by 75.5% to $7,235,611 compared to… Read more
Biome Australia launches 3 new Activated Probiotic products
● Biome has successfully launched three new clinically-trialled products into its Activated Probiotics® range ● Biome Dental™, Biome Lax™ and… Read more
